Net Income

Hain Celestial completes sale of Terra and Garden of Eatin' to pay down debt, betting its future on the high-margin tea, yogurt, and baby food markets.

Lynk Pharmaceuticals reports its oral drug zemprocitinib met all goals in a late-stage study for atopic dermatitis, offering rapid itch relief and a strong safety profile.

A key clinical milestone for its MS drug azer-cel nets Precision BioSciences $7.5M, extending its financial runway and boosting hope for patients.

With a strong cash runway and pivotal trials underway, Sionna Therapeutics aims to revolutionize CF treatment with a novel class of NBD1 stabilizer drugs.

As childhood nearsightedness soars, a new contact lens offers hope by not just correcting vision but actively slowing its progression in key global markets.

With strong leasing, strategic sales, and new developments, BXP is proving that a 'flight to quality' can defy the broader office market downturn.

As AI-driven fraud skyrockets, the Canadian Bankers Association is arming citizens with new resources to spot scams and protect their finances.

Riding record gold prices, TRX Gold shatters production records and cleans its balance sheet, fast-tracking a major expansion at its Buckreef project.

Zymeworks lands $250M from Royalty Pharma in a non-dilutive deal, validating its cancer drug Ziihera and highlighting a new era of biotech financing.

HVAC giant AAON reports record 2025 sales but lower earnings due to massive investments. A $1.83B backlog signals a powerful 2026 rebound.

Norwegian Cruise Line reports strong 2025 earnings but a weak 2026 outlook, as its new CEO points to internal missteps and charts a course for recovery.

With positive Phase 3 data for its first-in-class Stargardt disease drug and a massive new financing round, Belite Bio pivots toward commercialization.

Hudbay's acquisition of Arizona Sonoran creates a massive copper district, aiming to fuel the US green transition amid market jitters and local scrutiny.

With star-studded advisory board, a new biotech firm aims to turn routine dental visits into a frontline defense against oral cancer.

At MWC 2026, TechSee unveiled a platform that lets service providers see inside your home, promising to fix connectivity woes and cut churn.

Helios Consortium's formal offer for CAB Payments is rejected as 'opportunistic,' igniting a battle for control of the emerging markets payment specialist.

Activist fund GAM escalates its fight in Japan, filing an injunction to stop a Honda-backed squeeze-out it claims values a key auto parts business at zero.

An 8-month-old infant weighing just 5.5 kg receives a new liver from his father in a daring surgery, marking a milestone for pediatric care in India.

Indian firm Genus Power surpasses 26M smart meter deployments, leveraging its dominant role in national grid reform to expand its footprint worldwide.

At MWC 2026, MaxLinear showcases a single-chip solution enabling smaller, greener 5G radios, tackling key hurdles in the promising Open RAN market.